Antacids Market Size, Growth Analysis and Research Report 2024-2031 - Pfizer, GlaxoSmithKline & Abbott India Private Ltd.

The Global Antacids Market is expected to grow at a CAGR of 3.1% during the forecasting period (2024-2031).

DataM Intelligence has published a new research report on "Antacids Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Segmentation, CAGR, business revenue competitive positioning of key companies, investigating elements such as product offerings, pricing strategies, financial performance, product portfolios, growth initiatives, and geographical reach. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/antacids-market

Antacids are over-the-counter medications used to neutralize stomach acid and provide relief from symptoms associated with excess gastric acidity, such as heartburn, indigestion, and upset stomach. They work by increasing the pH level in the stomach, thereby alleviating discomfort and preventing the irritation of the esophagus. Common active ingredients in antacids include magnesium hydroxide, aluminum hydroxide, calcium carbonate, and sodium bicarbonate. While antacids are effective for short-term relief, they do not address the underlying causes of acid-related disorders. Frequent use should be monitored, as they may lead to side effects such as constipation or diarrhea, depending on the ingredient composition.

Key Developments:

➤ The rising prevalence of gastroesophageal reflux disease (GERD) is a key driver of the global antacids market. A review article published by the International Foundation for Gastrointestinal Disorders in 2014 indicated that GERD prevalence rates have been steadily increasing since 1995. In North America, the prevalence ranges from 18% to 28%, while Europe reports rates of 9% to 26%. East Asia shows a prevalence of 3% to 8%, Australia around 12%, the Middle East between 9% to 33%, and South America at approximately 23%. Notably, North America and East Asia have seen significant increases in GERD cases since 1995.

➤ Additionally, the growing incidence of heartburn is anticipated to further propel market growth during the forecast period. The American College of Gastroenterology reports that over 60 million Americans experience heartburn at least once a month, with more than 15 million individuals suffering from daily symptoms.

➤ Increased awareness of GERD also contributes to market growth. For example, the International Foundation for Gastrointestinal Disorders has actively supported GERD education and awareness initiatives, such as the 19th Annual GERD Awareness Week held in November 2018. These efforts aim to educate the public about GERD and promote research into treatments and potential cures for gastrointestinal disorders.

Research Process:

Both primary and secondary data sources have been used in the global Antacids Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

List of the Key Players in the Antacids Market:

Pfizer, GlaxoSmithKline, Abbott India Private Ltd, Merck, AstraZeneca PLC, Bayer AG, Takeda pharmaceuticals, Sun pharmaceuticals, Sanofi, Dr Reddy's Laboratories.

Segment Covered in the Antacids Market:

By Drug class: Proton pump inhibitors, H2 antagonists, Acid neutralizers.

By Formulation Type: Tablets, Liquids, Powders.

By End-User: Hospital Pharmacies, Retail pharmacies, others.

Regional Analysis:

The global Antacids Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/antacids-market

Regional Analysis:

The global Antacids Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Antacids Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Antacids manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Antacids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/antacids-market

Frequently Asked Questions

Q1) How Big is the Antacids Market?

A) The Global Antacids Market is expected to grow at a CAGR of 3.1% during the forecasting period (2024-2031).

Q2) Who are the key players of Antacids Market?

A) Pfizer, GlaxoSmithKline, Abbott India Private Ltd, Merck, AstraZeneca PLC, Bayer AG, Takeda pharmaceuticals, Sun pharmaceuticals, Sanofi, Dr Reddy's Laboratories.

Q3) What are the regions covered in this report?

A) The global Antacids Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa

4) What are the Segments Coverd in this report?

A) The Antacids market is segmented as By Drug Class, By Formulation Type, By End-User and By Region.

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.